108 related articles for article (PubMed ID: 24531350)
1. Perilesional enhancement of liver cavernous hemangiomas in magnetic resonance imaging.
Sousa MS; Ramalho M; Herédia V; Matos AP; Palas J; Jeon YH; Afonso D; Semelka RC
Abdom Imaging; 2014 Aug; 39(4):722-30. PubMed ID: 24531350
[TBL] [Abstract][Full Text] [Related]
2. MR diagnosis of hepatic metastases from neuroendocrine tumors versus hemangiomas: relative merits of dynamic gadolinium chelate-enhanced gradient-recalled echo and unenhanced spin-echo images.
Soyer P; Gueye C; Somveille E; Laissy JP; Scherrer A
AJR Am J Roentgenol; 1995 Dec; 165(6):1407-13. PubMed ID: 7484575
[TBL] [Abstract][Full Text] [Related]
3. Hepatic cavernous hemangioma: temporal peritumoral enhancement during multiphase dynamic MR imaging.
Jeong MG; Yu JS; Kim KW
Radiology; 2000 Sep; 216(3):692-7. PubMed ID: 10966696
[TBL] [Abstract][Full Text] [Related]
4. Cavernous hemangiomas in patients with chronic liver disease: MR imaging findings.
Mastropasqua M; Kanematsu M; Leonardou P; Braga L; Woosley JT; Semelka RC
Magn Reson Imaging; 2004 Jan; 22(1):15-8. PubMed ID: 14972389
[TBL] [Abstract][Full Text] [Related]
5. Lobulated margination of liver hemangiomas: Is this a definitive feature?
Matos AP; Jeon YH; Ramalho M; AlObaidy M; Semelka RC
Clin Imaging; 2016; 40(4):801-5. PubMed ID: 27130984
[TBL] [Abstract][Full Text] [Related]
6. [Multiple cavernous hemangioma progressing in size in a cirrhotic liver].
Henninger B; Bale R; Schocke M
Rofo; 2010 Apr; 182(4):357-9. PubMed ID: 19953432
[No Abstract] [Full Text] [Related]
7. Hepatic cavernous hemangioma: appearance on T2-weighted fast spin-echo MR imaging with and without fat suppression.
Soyer P; Dufresne AC; Somveille E; Scherrer A
AJR Am J Roentgenol; 1997 Feb; 168(2):461-5. PubMed ID: 9016227
[TBL] [Abstract][Full Text] [Related]
8. Hemangioma in the cirrhotic liver: diagnosis and natural history.
Brancatelli G; Federle MP; Blachar A; Grazioli L
Radiology; 2001 Apr; 219(1):69-74. PubMed ID: 11274536
[TBL] [Abstract][Full Text] [Related]
9. Submillimeter-pixel MR images of hepatic cavernous hemangiomas.
Maeda H; Hayashi N; Toyooka N; Endoh S; Hayashi R
Radiat Med; 1997; 15(1):17-22. PubMed ID: 9134580
[TBL] [Abstract][Full Text] [Related]
10. Additional Diagnostic Value of Inversion Recovery Single-Shot Fast-Spin Echo Sequence in Differentiation Between Hepatic Hemangiomas and Cysts.
Atman ED; Erden A; Uzun Ç; Yavuz Y
J Comput Assist Tomogr; 2015; 39(4):483-8. PubMed ID: 25955398
[TBL] [Abstract][Full Text] [Related]
11. Ultra-low field MR imaging of hepatic hemangiomas (at 0.02 and 0.04 T).
Ekelund L; Björnebrink J; Athlin L
Eur J Radiol; 1992; 14(1):41-5. PubMed ID: 1563403
[TBL] [Abstract][Full Text] [Related]
12. Transient peritumoral enhancement during dynamic MRI of the liver: cavernous hemangioma versus hepatocellular carcinoma.
Yu JS; Kim KW; Park MS; Yoon SW
J Comput Assist Tomogr; 2002; 26(3):411-7. PubMed ID: 12016371
[TBL] [Abstract][Full Text] [Related]
13. Distinction between cavernous hemangiomas of the liver and hepatic metastases on CT: value of contrast enhancement patterns.
Leslie DF; Johnson CD; Johnson CM; Ilstrup DM; Harmsen WS
AJR Am J Roentgenol; 1995 Mar; 164(3):625-9. PubMed ID: 7863883
[TBL] [Abstract][Full Text] [Related]
14. Temporal peritumoral enhancement of hepatic cavernous hemangioma: findings at multiphase dynamic magnetic resonance imaging.
Li CS; Chen RC; Chen WT; Lii JM; Tu HY
J Comput Assist Tomogr; 2003; 27(6):854-9. PubMed ID: 14600449
[TBL] [Abstract][Full Text] [Related]
15. Hepatic hemangiomas: difference in enhancement pattern on 3T MR imaging with gadobenate dimeglumine versus gadoxetate disodium.
Gupta RT; Marin D; Boll DT; Husarik DB; Davis DE; Feuerlein S; Merkle EM
Eur J Radiol; 2012 Oct; 81(10):2457-62. PubMed ID: 22138122
[TBL] [Abstract][Full Text] [Related]
16. Atypically enhancing hepatic cavernous hemangiomas: high-spatial-resolution gadolinium-enhanced triphasic dynamic gradient-recalled-echo imaging findings.
Kato H; Kanematsu M; Matsuo M; Kondo H; Hoshi H
Eur Radiol; 2001; 11(12):2510-5. PubMed ID: 11734950
[TBL] [Abstract][Full Text] [Related]
17. Hepatic metastases and cavernous hemangiomas: distinction with standard- and triple-dose gadoteridol-enhanced MR imaging.
Mitchell DG; Saini S; Weinreb J; De Lange EE; Runge VM; Kuhlman JE; Parisky Y; Johnson CD; Brown JJ; Schnall M
Radiology; 1994 Oct; 193(1):49-57. PubMed ID: 8090921
[TBL] [Abstract][Full Text] [Related]
18. Hepatic hemangiomas: factors associated with T2 shine-through effect on diffusion-weighted MR sequences.
Duran R; Ronot M; Kerbaol A; Van Beers B; Vilgrain V
Eur J Radiol; 2014 Mar; 83(3):468-78. PubMed ID: 24364922
[TBL] [Abstract][Full Text] [Related]
19. Hepatic cavernous hemangioma in cirrhotic liver: imaging findings.
Yu JS; Kim KW; Park MS; Yoon SW
Korean J Radiol; 2000; 1(4):185-90. PubMed ID: 11752953
[TBL] [Abstract][Full Text] [Related]
20. Differentiation between cavernous hemangiomas and untreated malignant neoplasms of the liver with free-breathing diffusion-weighted MR imaging: comparison with T2-weighted fast spin-echo MR imaging.
Soyer P; Corno L; Boudiaf M; Aout M; Sirol M; Placé V; Duchat F; Guerrache Y; Fargeaudou Y; Vicaut E; Pocard M; Hamzi L
Eur J Radiol; 2011 Nov; 80(2):316-24. PubMed ID: 20800983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
